Eucabal syrup 100 ml — Made in Germany — Free Delivery

Pharmacokinetics. Substances contained in liquid extracts of both plantain and thyme (thyme), including essential oils, as expectorants, affect the properties, formation and transport of bronchial secretions.

It is carried out as an indirect reflex effect through the gastric mucosa, and the direct effect of essential oils on the bronchial glands, which enhances their activity. This contributes to the increase, liquefaction and dissolution of bronchial secretions, as well as increased transport of secretions through the ciliated epithelium. This is especially important in the later stages of acute bronchitis and in chronic bronchitis, when there is an increased secretion of viscous mucus by the submucous glands. In addition, essential oils, due to their surface activity, reduce the binding capacity of highly viscous mucus on the mucous membrane of the trachea and bronchi.

Thyme is characterized by the pronounced antimicrobial potential of thymol and carvacrol. Plantain mucous substances help to protect the damaged bronchial mucosa from further irritation.

Pharmacodynamics. Has not been investigated.

Symptomatic treatment for inflammatory diseases of the respiratory tract. expectorant for the symptomatic treatment of a productive cough. whooping cough supportive.

Children aged 4 to 6 years are prescribed 1 teaspoon (5 ml) 3-5 times a day. children aged 6 to 12 years - 1 dessert spoon (10 ml) 3-5 times a day. children over the age of 12 and adults are prescribed 1-2 dessert spoons (10-20 ml) 3-5 times a day.

The duration of treatment is determined by the doctor individually, it depends on the course of the disease and the state of health of the patient.

Hypersensitivity to the components of the preparation, fructose intolerance; hypersensitivity to alkyl 4-hydroxybenzoate. hypersensitivity to plants of the lamiaceae family, celery and birch pollen (cross-reaction is possible).

Gastroesophageal reflux disease, including reflux esophagitis, gastritis with high acidity of gastric juice, gastric and duodenal ulcers, severe liver or kidney disease.

Possible gastrointestinal disorders (including nausea, vomiting, diarrhea), hypersensitivity reactions, including rash, urticaria, pruritus, angioedema, shortness of breath, exanthema.

Shake the syrup in the bottle before use. the presence of herbal ingredients in the preparation may cause turbidity of the syrup, however, the therapeutic efficacy of the preparation does not decrease from this.

Eucabal syrup contains 6.5 vol% ethanol, which creates a risk for patients with epilepsy, chronic alcoholism, liver diseases, organic brain diseases.

Do not use in patients with fructose intolerance, malabsorption of glucose-galactose or sucrose-isomaltose. Due to the sugar content, it can be harmful to the teeth (tooth decay).

At the first sign of hypersensitivity reactions, the preparation should not be continued.

Use with caution in patients with diabetes mellitus. Eucabal syrup contains glucose, fructose and sucrose with a total sugar content in terms of sucrose of 0.6 g / ml. Thus, 1 teaspoon (5 ml) contains 3 g of sucrose or 0.25 bread units, and 1 dessert spoon (10 ml) contains 6 g of sucrose or 0.5 bread units.

Do not use simultaneously with antitussive preparations and preparations that reduce sputum production. due to the ethanol content (6.5 vol.%), there is a possibility of deterioration or enhancement of the action of other preparations.

Symptoms in case of an overdose, nausea may appear, accompanied by a cough.

Treatment. Cancellation of the preparation. Therapy is symptomatic.

In a dark place at temperatures up to 25 ° C.